<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=utf-8"><meta name=Generator content="Microsoft Word 12 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><title>Register now for CCSN's November 12 webinar on biologics & biosimilars!</title><style><!--
/* Font Definitions */
@font-face
{font-family:Helvetica;
panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
{font-family:Georgia;
panose-1:2 4 5 2 5 4 5 2 3 3;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
h1
{mso-style-priority:9;
mso-style-link:"Heading 1 Char";
margin:0cm;
margin-bottom:.0001pt;
line-height:125%;
font-size:30.0pt;
font-family:"Helvetica","sans-serif";
color:#606060;
letter-spacing:-.75pt;
font-weight:bold;}
h2
{mso-style-priority:9;
mso-style-link:"Heading 2 Char";
margin:0cm;
margin-bottom:.0001pt;
line-height:125%;
font-size:19.5pt;
font-family:"Helvetica","sans-serif";
color:#404040;
letter-spacing:-.55pt;
font-weight:bold;}
h3
{mso-style-priority:9;
mso-style-link:"Heading 3 Char";
margin:0cm;
margin-bottom:.0001pt;
line-height:125%;
font-size:13.5pt;
font-family:"Helvetica","sans-serif";
color:#606060;
letter-spacing:-.4pt;
font-weight:bold;}
h4
{mso-style-priority:9;
mso-style-link:"Heading 4 Char";
margin:0cm;
margin-bottom:.0001pt;
line-height:125%;
font-size:12.0pt;
font-family:"Helvetica","sans-serif";
color:gray;
font-weight:bold;}
h5
{mso-style-priority:9;
mso-style-link:"Heading 5 Char";
margin:0cm;
margin-bottom:.0001pt;
font-size:10.0pt;
font-family:"Times New Roman","serif";
font-weight:bold;}
h6
{mso-style-priority:9;
mso-style-link:"Heading 6 Char";
margin:0cm;
margin-bottom:.0001pt;
font-size:7.5pt;
font-family:"Times New Roman","serif";
font-weight:bold;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p
{mso-style-priority:99;
margin-top:12.0pt;
margin-right:0cm;
margin-bottom:12.0pt;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
span.Heading1Char
{mso-style-name:"Heading 1 Char";
mso-style-priority:9;
mso-style-link:"Heading 1";
font-family:"Cambria","serif";
color:#365F91;
font-weight:bold;}
span.Heading2Char
{mso-style-name:"Heading 2 Char";
mso-style-priority:9;
mso-style-link:"Heading 2";
font-family:"Cambria","serif";
color:#4F81BD;
font-weight:bold;}
span.Heading3Char
{mso-style-name:"Heading 3 Char";
mso-style-priority:9;
mso-style-link:"Heading 3";
font-family:"Cambria","serif";
color:#4F81BD;
font-weight:bold;}
span.Heading4Char
{mso-style-name:"Heading 4 Char";
mso-style-priority:9;
mso-style-link:"Heading 4";
font-family:"Cambria","serif";
color:#4F81BD;
font-weight:bold;
font-style:italic;}
span.Heading5Char
{mso-style-name:"Heading 5 Char";
mso-style-priority:9;
mso-style-link:"Heading 5";
font-family:"Cambria","serif";
color:#243F60;}
span.Heading6Char
{mso-style-name:"Heading 6 Char";
mso-style-priority:9;
mso-style-link:"Heading 6";
font-family:"Cambria","serif";
color:#243F60;
font-style:italic;}
p.readmsgbody, li.readmsgbody, div.readmsgbody
{mso-style-name:readmsgbody;
margin-top:12.0pt;
margin-right:0cm;
margin-bottom:12.0pt;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
p.externalclass, li.externalclass, div.externalclass
{mso-style-name:externalclass;
margin-top:12.0pt;
margin-right:0cm;
margin-bottom:12.0pt;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
p.mcnimage, li.mcnimage, div.mcnimage
{mso-style-name:mcnimage;
margin-top:12.0pt;
margin-right:0cm;
margin-bottom:12.0pt;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
p.mcntextcontent, li.mcntextcontent, div.mcntextcontent
{mso-style-name:mcntextcontent;
margin-top:12.0pt;
margin-right:0cm;
margin-bottom:12.0pt;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
p.mcntextcontent1, li.mcntextcontent1, div.mcntextcontent1
{mso-style-name:mcntextcontent1;
margin-top:12.0pt;
margin-right:0cm;
margin-bottom:12.0pt;
margin-left:0cm;
line-height:125%;
font-size:8.5pt;
font-family:"Helvetica","sans-serif";
color:#606060;}
p.mcntextcontent2, li.mcntextcontent2, div.mcntextcontent2
{mso-style-name:mcntextcontent2;
margin-top:12.0pt;
margin-right:0cm;
margin-bottom:12.0pt;
margin-left:0cm;
line-height:150%;
font-size:11.5pt;
font-family:"Helvetica","sans-serif";
color:#606060;}
p.mcntextcontent3, li.mcntextcontent3, div.mcntextcontent3
{mso-style-name:mcntextcontent3;
margin-top:12.0pt;
margin-right:0cm;
margin-bottom:12.0pt;
margin-left:0cm;
line-height:150%;
font-size:11.5pt;
font-family:"Helvetica","sans-serif";
color:#606060;}
p.mcntextcontent4, li.mcntextcontent4, div.mcntextcontent4
{mso-style-name:mcntextcontent4;
margin-top:12.0pt;
margin-right:0cm;
margin-bottom:12.0pt;
margin-left:0cm;
line-height:150%;
font-size:11.5pt;
font-family:"Helvetica","sans-serif";
color:#606060;}
p.mcntextcontent5, li.mcntextcontent5, div.mcntextcontent5
{mso-style-name:mcntextcontent5;
margin-top:12.0pt;
margin-right:0cm;
margin-bottom:12.0pt;
margin-left:0cm;
line-height:150%;
font-size:11.5pt;
font-family:"Helvetica","sans-serif";
color:#606060;}
p.mcntextcontent6, li.mcntextcontent6, div.mcntextcontent6
{mso-style-name:mcntextcontent6;
margin-top:12.0pt;
margin-right:0cm;
margin-bottom:12.0pt;
margin-left:0cm;
line-height:125%;
font-size:8.5pt;
font-family:"Helvetica","sans-serif";
color:#606060;}
span.org
{mso-style-name:org;}
span.locality
{mso-style-name:locality;}
span.region
{mso-style-name:region;}
span.postal-code
{mso-style-name:postal-code;}
span.EmailStyle40
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1027" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body bgcolor="#F2F2F2" lang=EN-CA link=blue vlink=purple><div class=WordSection1><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Hi all:<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>See below wrt a CCSN webinar.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Sign up if you wish.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Thx.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Glen<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'><o:p> </o:p></span></p><div><div style='border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0cm 0cm 0cm'><p class=MsoNormal><b><span lang=EN-US style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'>From:</span></b><span lang=EN-US style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'> Canadian Cancer Survivor Network [mailto:info=survivornet.ca@mail41.suw15.mcsv.net] <b>On Behalf Of </b>Canadian Cancer Survivor Network<br><b>Sent:</b> November 5, 2015 12:41 PM<br><br><b>Subject:</b> Register now for CCSN's November 12 webinar on biologics & biosimilars!<o:p></o:p></span></p></div></div><p class=MsoNormal><o:p> </o:p></p><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;background:#F2F2F2;border-collapse:collapse'><tr><td width="100%" valign=top style='width:100.0%;padding:15.0pt 15.0pt 15.0pt 15.0pt'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;background:white;border-collapse:collapse'><tr><td valign=top style='padding:6.75pt 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=366 style='width:274.5pt;border-collapse:collapse'><tr><td valign=top style='padding:6.75pt 0cm 6.75pt 13.5pt'><p class=MsoNormal style='line-height:125%'><span style='font-size:7.5pt;line-height:125%;font-family:"Tahoma","sans-serif";color:#606060'>Welcome to the Canadian Cancer Survivor Network's webinar newsletter!</span><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'> <o:p></o:p></span></p></td></tr></table><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=right width=197 style='width:147.75pt;border-collapse:collapse'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 0cm'><p class=MsoNormal align=right style='text-align:right;line-height:125%'><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'><a href="http://us8.campaign-archive2.com/?u=318d4e052fdd9593317146113&id=fd9bb6847e&e=79f909daf9" target="_blank"><span style='color:#606060'>View this email in your browser</span></a><o:p></o:p></span></p></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 6.75pt 6.75pt 6.75pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 6.75pt 0cm 6.75pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal align=center style='text-align:center'><a href="http://survivornet.us8.list-manage1.com/track/click?u=318d4e052fdd9593317146113&id=2265b7846b&e=79f909daf9" target="_blank" title=""><span style='text-decoration:none'><img border=0 width=282 id="_x0000_i1025" src="http://gallery.mailchimp.com/318d4e052fdd9593317146113/images/24fd085a-1beb-44ce-ad4f-d6670f04e815.jpg"></span></a><o:p></o:p></p></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 6.75pt 6.75pt 6.75pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 6.75pt 0cm 6.75pt;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal><a href="http://survivornet.us8.list-manage2.com/track/click?u=318d4e052fdd9593317146113&id=01e848460b&e=79f909daf9" target="_blank" title=""></a><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
<v:stroke joinstyle="miter" />
<v:formulas>
<v:f eqn="if lineDrawn pixelLineWidth 0" />
<v:f eqn="sum @0 1 0" />
<v:f eqn="sum 0 0 @1" />
<v:f eqn="prod @2 1 2" />
<v:f eqn="prod @3 21600 pixelWidth" />
<v:f eqn="prod @3 21600 pixelHeight" />
<v:f eqn="sum @0 0 1" />
<v:f eqn="prod @6 1 2" />
<v:f eqn="prod @7 21600 pixelWidth" />
<v:f eqn="sum @8 21600 0" />
<v:f eqn="prod @7 21600 pixelHeight" />
<v:f eqn="sum @10 21600 0" />
</v:formulas>
<v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect" />
<o:lock v:ext="edit" aspectratio="t" />
</v:shapetype><v:shape id="_x0000_s1026" type="#_x0000_t75" alt="" href="http://survivornet.us8.list-manage2.com/track/click?u=318d4e052fdd9593317146113&id=01e848460b&e=79f909daf9" target=""_blank"" title="""" style='position:absolute;margin-left:0;margin-top:0;width:423pt;height:168.75pt;z-index:251658240;mso-wrap-distance-left:0;mso-wrap-distance-top:0;mso-wrap-distance-right:0;mso-wrap-distance-bottom:0;mso-position-horizontal:left;mso-position-horizontal-relative:text;mso-position-vertical-relative:line' o:allowoverlap="f" o:button="t">
<v:imagedata src="https://gallery.mailchimp.com/318d4e052fdd9593317146113/images/038f12de-687a-428e-bbb4-77e5876e8ba7.png" />
<w:wrap type="square"/>
</v:shape><![endif]--><![if !vml]><a href="http://survivornet.us8.list-manage2.com/track/click?u=318d4e052fdd9593317146113&id=01e848460b&e=79f909daf9" target=""_blank""><img border=0 width=564 height=225 src="https://gallery.mailchimp.com/318d4e052fdd9593317146113/images/038f12de-687a-428e-bbb4-77e5876e8ba7.png" align=left title="""" v:shapes="_x0000_s1026"></a><![endif]><a href="http://survivornet.us8.list-manage2.com/track/click?u=318d4e052fdd9593317146113&id=01e848460b&e=79f909daf9" target="_blank" title=""></a><o:p></o:p></p></td></tr></table></td></tr></table></td></tr></table></div></td></tr><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;background:white;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%' id=templateHeader><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal style='line-height:200%'><a name="drug_plan_webinar" id="drug plan webinar"><strong><u><span style='font-size:16.5pt;line-height:200%;font-family:"Tahoma","sans-serif";color:purple'>What is a Biosimilar? All You Need to Know About Biologics & Biosimilars in Canada</span></u></strong></a><span style='font-size:11.5pt;line-height:200%;font-family:"Helvetica","sans-serif";color:#606060'> <o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table></div></td></tr><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;background:white;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%' id=templateBody><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal style='line-height:150%'><span style='font-size:10.5pt;line-height:150%;font-family:"Tahoma","sans-serif";color:#606060'>Our next webinar is titled </span><em><span style='font-size:11.5pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#606060'>What is a biosimilar? All you need to know about the current biologics and biosimilars landscape in Canada</span></em><span style='font-size:10.5pt;line-height:150%;font-family:"Tahoma","sans-serif";color:#606060'>, and will take place on <strong><span style='font-family:"Tahoma","sans-serif"'>Thursday, November 12th</span></strong> from <strong><span style='font-family:"Tahoma","sans-serif"'>1:30pm EDT - 2:30pm EST. </span></strong>This webinar will be presented by <strong><span style='font-family:"Tahoma","sans-serif"'>Karen Burke, Ph.D. </span></strong>of<strong><span style='font-family:"Tahoma","sans-serif"'> Amgen Canada, Inc. </span></strong></span><span style='font-size:11.5pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#606060'> <o:p></o:p></span></p></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal style='line-height:150%'><strong><u><span style='font-size:10.5pt;line-height:150%;font-family:"Tahoma","sans-serif";color:#606060'>Webinar Information</span></u></strong><span style='font-size:11.5pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#606060'> <o:p></o:p></span></p></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><div><p class=MsoNormal style='line-height:150%'><span style='font-size:10.5pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#606060'>The webinar is broken out into two parts:</span><span style='font-size:11.5pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#606060'><br><br><strong><span style='font-family:"Helvetica","sans-serif"'>Part 1:</span></strong><em><span style='font-family:"Helvetica","sans-serif"'> Biologics</span></em> - The first part of the presentation will focus on biologics, including an explanation of the high level of precision that is required to produce a consistent biological product each time.<br><br><strong><span style='font-family:"Helvetica","sans-serif"'>Part 2:</span></strong><em><span style='font-family:"Helvetica","sans-serif"'> Biosimilars</span></em> – The second part of the presentation will focus on the growing interest in biosimilars, followed by what we can learn from Europe’s experience. We will also provide Health Canada’s position on biosimilars, discuss key issues surrounding biosimilars relevant to the Canadian market, as well as, the importance of patient safety and patient choice.<br><br>Following the presentation, there will be an interactive discussion where listeners will have an opportunity to ask questions and continue the dialogue on biologic medicines and biosimilars.<o:p></o:p></span></p></div></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:13.5pt 13.5pt 13.5pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='border:none;border-top:solid #999999 1.0pt;padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=600 style='width:450.0pt;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal style='line-height:150%'><strong><u><span style='font-size:10.5pt;line-height:150%;font-family:"Tahoma","sans-serif";color:#606060'>Presenter Information</span></u></strong><span style='font-size:11.5pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#606060'><o:p></o:p></span></p></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 6.75pt 6.75pt 6.75pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 6.75pt 0cm 6.75pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left style='border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal><img border=0 width=176 id="_x0000_i1026" src="https://gallery.mailchimp.com/318d4e052fdd9593317146113/images/a40883d9-eb0f-4ab9-9f55-847938239b69.jpg"><o:p></o:p></p></td></tr></table><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=right width=352 style='width:264.0pt;border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:150%'><span style='font-size:10.5pt;line-height:150%;font-family:"Tahoma","sans-serif";color:#606060'>Karen A. Burke, Ph.D., is the Director of Regulatory Affairs at Amgen Canada Inc, a role she has held since 2006. She is also interim Regulatory Affairs lead for Amgen’s Intercontinental Region. </span><span style='font-size:11.5pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#606060'><br><br>Since obtaining her Ph.D. in Organometallic Chemistry from McMaster University, Karen has worked in the pharmaceutical industry in several roles over a career of more than 20 years, including positions in Operations and in Regulatory Affairs at Astra Pharma/AstraZeneca Canada Inc. <o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=600 style='width:450.0pt;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 13.5pt 13.5pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><div align=center><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 style='background:#843179;border-collapse:collapse;border:none;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='border:solid #707070 1.5pt;padding:12.0pt 12.0pt 12.0pt 12.0pt;border-radius: 5px;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal align=center style='text-align:center'><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=b8fff73503&e=79f909daf9" target="_blank" title="Click HERE to register for this webinar!"><b><span style='font-family:"Arial","sans-serif";color:white;text-decoration:none'>Click HERE to register for this webinar!</span></b></a><span style='font-family:"Arial","sans-serif"'> <o:p></o:p></span></p></td></tr></table></div></td></tr></table></td></tr></table></div></td></tr><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;background:white;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%' id=templateColumns><tr><td width="50%" valign=top style='width:50.0%;padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'></td></tr></table></td><td width="50%" valign=top style='width:50.0%;padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'></td></tr></table></td></tr></table></div></td></tr><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;background:white;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%' id=templateFooter><tr><td valign=top style='padding:0cm 0cm 6.75pt 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:13.5pt 13.5pt 13.5pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='border:none;border-top:solid #999999 1.0pt;padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=600 style='width:450.0pt;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal style='line-height:200%'><strong><u><span style='font-size:16.5pt;line-height:200%;font-family:"Tahoma","sans-serif";color:purple'>Follow us on our social media pages!</span></u></strong><span style='font-size:8.5pt;line-height:200%;font-family:"Helvetica","sans-serif";color:#606060'> <o:p></o:p></span></p></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal style='line-height:10.3pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><strong><span style='font-size:9.0pt;font-family:"Tahoma","sans-serif";color:purple'>Twitter</span></strong><span style='font-size:8.5pt;font-family:"Helvetica","sans-serif";color:#606060'><br></span><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";color:#606060'><a href="http://survivornet.us8.list-manage2.com/track/click?u=318d4e052fdd9593317146113&id=86a80e8b12&e=79f909daf9" target="_blank">@survivornetca</a> - our main twitter account of information, news and resources on all cancers<br><a href="http://survivornet.us8.list-manage2.com/track/click?u=318d4e052fdd9593317146113&id=94d17a186e&e=79f909daf9" target="_blank">@bestbreastnews</a> - information on breast health and breast cancer<br><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=9f00827d7a&e=79f909daf9" target="_blank">@prostatepost</a> - news, events and resources on prostate cancer<br><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=0b33afa839&e=79f909daf9" target="_blank">@canadianmeso</a> - details on asbestos and mesothelioma<br><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=7b18e371cd&e=79f909daf9" target="_blank">@LungCancerCan</a> - focuses on lung cancer news, events and awareness<br><a href="http://survivornet.us8.list-manage1.com/track/click?u=318d4e052fdd9593317146113&id=6807a19477&e=79f909daf9" target="_blank">@CCSNpoli</a> - general, non-partisan talk about the politics of healthcare and cancer care<br><a href="http://survivornet.us8.list-manage1.com/track/click?u=318d4e052fdd9593317146113&id=5884ac8ee4&e=79f909daf9" target="_blank">@MedMarijuanaCan</a> - news and information regarding medical marijuana<br><a href="http://survivornet.us8.list-manage2.com/track/click?u=318d4e052fdd9593317146113&id=25219502d2&e=79f909daf9" target="_blank">@s</a><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=ce3df2af92&e=79f909daf9">tomachcancerca</a> - information and resources on stomach cancer <br><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=91742fae6c&e=79f909daf9" target="_blank">@</a><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=102ec255d1&e=79f909daf9">cervicalcanca</a> - information and resources on cervical cancer<br><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=7c31fe4719&e=79f909daf9" target="_blank">@</a><a href="http://survivornet.us8.list-manage1.com/track/click?u=318d4e052fdd9593317146113&id=075a34f6d5&e=79f909daf9">melanomacan</a> - information and resources on melanoma</span><span style='font-size:8.5pt;font-family:"Helvetica","sans-serif";color:#606060'><o:p></o:p></span></p><p class=MsoNormal style='mso-line-height-alt:10.3pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:13.0pt;font-family:"Georgia","serif";color:#606060'> </span><span style='font-size:8.5pt;font-family:"Helvetica","sans-serif";color:#606060'><o:p></o:p></span></p><p class=MsoNormal style='line-height:10.3pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><strong><span style='font-size:9.0pt;font-family:"Tahoma","sans-serif";color:purple'>Facebook</span></strong><span style='font-size:8.5pt;font-family:"Helvetica","sans-serif";color:#606060'><br></span><span style='font-size:9.0pt;font-family:"Tahoma","sans-serif";color:#606060'><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=836f3c3148&e=79f909daf9" target="_blank">Click here to 'like' us on Facebook!</a><br>Pages dedicated to <a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=816145f5a1&e=79f909daf9" target="_blank">asbestos and mesothelioma</a> and <a href="http://survivornet.us8.list-manage2.com/track/click?u=318d4e052fdd9593317146113&id=ccc3bd946e&e=79f909daf9" target="_blank">prostate cancer!</a></span><span style='font-size:8.5pt;font-family:"Helvetica","sans-serif";color:#606060'><br><br></span><strong><span style='font-size:9.0pt;font-family:"Tahoma","sans-serif";color:purple'>YouTube</span></strong><span style='font-size:8.5pt;font-family:"Helvetica","sans-serif";color:#606060'><br><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=5542ee0783&e=79f909daf9" target="_blank"><span style='font-size:9.0pt'>Click here to subscribe to our YouTube channel!</span></a><o:p></o:p></span></p><p class=MsoNormal style='mso-line-height-alt:10.3pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:13.0pt;font-family:"Georgia","serif";color:#606060'> </span><span style='font-size:8.5pt;font-family:"Helvetica","sans-serif";color:#606060'><o:p></o:p></span></p><p class=MsoNormal style='line-height:10.3pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><strong><span style='font-size:9.0pt;font-family:"Tahoma","sans-serif";color:purple'>Slideshare</span></strong><span style='font-size:8.5pt;font-family:"Helvetica","sans-serif";color:#606060'><br><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=e600b23f85&e=79f909daf9" target="_blank"><span style='font-size:9.0pt;font-family:"Tahoma","sans-serif"'>Click here to follow our slideshare page!</span></a><br><br></span><strong><span style='font-size:9.0pt;font-family:"Tahoma","sans-serif";color:purple'>Pinterest</span></strong><span style='font-size:8.5pt;font-family:"Helvetica","sans-serif";color:#606060'><br></span><span style='font-size:9.0pt;font-family:"Tahoma","sans-serif";color:#606060'><a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=844b2b635c&e=79f909daf9" target="_blank">Follow us on our Pinterest page!</a></span><span style='font-size:8.5pt;font-family:"Helvetica","sans-serif";color:#606060'><o:p></o:p></span></p><p class=MsoNormal style='mso-line-height-alt:10.3pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:13.0pt;font-family:"Georgia","serif";color:#606060'> </span><span style='font-size:8.5pt;font-family:"Helvetica","sans-serif";color:#606060'><o:p></o:p></span></p><p class=MsoNormal style='line-height:10.3pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><strong><span style='font-size:9.0pt;font-family:"Tahoma","sans-serif";color:purple'>Blog</span></strong><span style='font-size:8.5pt;font-family:"Helvetica","sans-serif";color:#606060'><br></span><span style='font-size:9.0pt;font-family:"Tahoma","sans-serif";color:#606060'>Follow our main blog: <a href="http://survivornet.us8.list-manage.com/track/click?u=318d4e052fdd9593317146113&id=4be20aa410&e=79f909daf9" target="_blank">Jackie Manthorne's Cancer Blog</a><br>Follow our blog focused on asbestos and mesothelioma: <a href="http://survivornet.us8.list-manage1.com/track/click?u=318d4e052fdd9593317146113&id=5b975293f6&e=79f909daf9" target="_blank">Canadian Meso Blog</a></span><span style='font-size:8.5pt;font-family:"Helvetica","sans-serif";color:#606060'><o:p></o:p></span></p><p class=MsoNormal style='line-height:10.3pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:8.5pt;font-family:"Helvetica","sans-serif";color:#606060'><br></span><strong><span style='font-size:9.0pt;font-family:"Tahoma","sans-serif";color:purple'>Weekly newsletter</span></strong><span style='font-size:9.0pt;font-family:"Tahoma","sans-serif";color:#606060'><br><a href="http://survivornet.us8.list-manage2.com/track/click?u=318d4e052fdd9593317146113&id=066dd4683b&e=79f909daf9" target="_blank">Click here to subscribe to our weekly newsletter!</a></span><span style='font-size:8.5pt;font-family:"Helvetica","sans-serif";color:#606060'><o:p></o:p></span></p></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:13.5pt 13.5pt 13.5pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='border:none;border-top:solid #999999 1.0pt;padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=600 style='width:450.0pt;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal style='line-height:15.6pt'><em><span style='font-size:8.5pt;font-family:"Helvetica","sans-serif";color:#606060'>Copyright © 2015 Canadian Cancer Survivor Network, All rights reserved.</span></em><span style='font-size:8.5pt;font-family:"Helvetica","sans-serif";color:#606060'><br><br>You are receiving this email because you subscribed to it.<br><br><strong><span style='font-family:"Helvetica","sans-serif"'>Our mailing address is:</span></strong><o:p></o:p></span></p><div><p class=MsoNormal style='line-height:15.6pt'><span class=org><span style='font-size:8.5pt;font-family:"Helvetica","sans-serif";color:#606060'>Canadian Cancer Survivor Network</span></span><span style='font-size:8.5pt;font-family:"Helvetica","sans-serif";color:#606060'><o:p></o:p></span></p><div><div><p class=MsoNormal style='line-height:15.6pt'><span style='font-size:8.5pt;font-family:"Helvetica","sans-serif";color:#606060'>1750 Courtwood Crescent<o:p></o:p></span></p></div><div><p class=MsoNormal style='line-height:15.6pt'><span style='font-size:8.5pt;font-family:"Helvetica","sans-serif";color:#606060'>Suite 210<o:p></o:p></span></p></div><p class=MsoNormal style='line-height:15.6pt'><span class=locality><span style='font-size:8.5pt;font-family:"Helvetica","sans-serif";color:#606060'>Ottawa</span></span><span style='font-size:8.5pt;font-family:"Helvetica","sans-serif";color:#606060'>, <span class=region>ON</span> <span class=postal-code>K2C 2B5</span> <o:p></o:p></span></p><div><p class=MsoNormal style='line-height:15.6pt'><span style='font-size:8.5pt;font-family:"Helvetica","sans-serif";color:#606060'>Canada<o:p></o:p></span></p></div></div><p class=MsoNormal style='line-height:15.6pt'><span style='font-size:8.5pt;font-family:"Helvetica","sans-serif";color:#606060'><br><a href="http://survivornet.us8.list-manage1.com/vcard?u=318d4e052fdd9593317146113&id=f2916c1a7e"><span style='color:#606060'>Add us to your address book</span></a><o:p></o:p></span></p></div><p class=MsoNormal style='margin-bottom:12.0pt;line-height:125%'><span style='font-size:8.5pt;line-height:125%;font-family:"Helvetica","sans-serif";color:#606060'><br><br><a href="http://survivornet.us8.list-manage.com/unsubscribe?u=318d4e052fdd9593317146113&id=f2916c1a7e&e=79f909daf9&c=fd9bb6847e"><span style='color:#606060'>unsubscribe from this list</span></a> <a href="http://survivornet.us8.list-manage1.com/profile?u=318d4e052fdd9593317146113&id=f2916c1a7e&e=79f909daf9"><span style='color:#606060'>update subscription preferences</span></a> <o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table></div></td></tr></table></div></td></tr></table></div><p class=MsoNormal><img border=0 width=1 height=1 id="_x0000_i1027" src="http://survivornet.us8.list-manage.com/track/open.php?u=318d4e052fdd9593317146113&id=fd9bb6847e&e=79f909daf9"><o:p></o:p></p></div></body></html>